Die Novartis-Aktie verzeichnete am jüngsten Handelstag eine positive Entwicklung an der Schweizer Börse SIX. Im Tagesverlauf stieg der Kurs um 0,7 Prozent auf 92,62 CHF, nachdem er bei 91,90 CHF in de ...
Midtown-based drug discovery company Schrodinger has entered a deal to advance multiple projects with pharmaceutical giant ...
Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.
In a significant stride within the pharmaceutical industry, Midtown's own Schrödinger has clinched a deal with healthcare ...
In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Schrodinger (SDGR – Research Report), with a ...
An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...
Die Nachrichten kamen an der Börse gut an; die Aktie beendete den US-Handel mit einem satten Kursplus von 13 Prozent. Laut ...
Physics-based US software specialist Schrödinger’s shares leapt nearly 14% to $22.25 on the back of news that it has entered ...
In its recent earnings release for the third quarter of 2024, Schrödinger reported significant developments, including a new collaboration with Novartis, which will see an upfront payment of $150 ...
Also, Novartis AG will pay computational-chemistry expert Schrödinger Inc. $150 million up front and as much as $2.3 billion in milestones to develop several candidates along with up to $892 million ...
Dutch firm Argenx Euronext: ARGX) and China’s Zai Lab (HKEX: 9688) have received an approval from the National Medical ...
NEW YORK - Schrödinger, Inc. (NASDAQ: SDGR), ein Unternehmen, das sich auf computergestützte molekulare Entdeckungen spezialisiert hat, gab eine bedeutende Kooperations- und Lizenzvereinbarung mit dem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback